February 2019, Vol 12, No 1, Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections

Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
Kenneth LaPensee, PhD, MPH, Rohit Mistry, MPharm, MBA, MSc, Thomas Lodise, PharmD, PhD
February 2019, Vol 12, No 1, Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
Treatment of acute bacterial skin and skin structure infections (ABSSSI) places a significant burden on the healthcare system, primarily due to expenditures associated with hospitalization costs. This publication details the results of a budget impact model study designed to estimate the potential annual budget impact of introducing omadacycline as a treatment option for patients with ABSSSI who present to the emergency department for care.
Read More

Results 1 - 1 of 1
  • Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME